
Decrease of cardiovascular risk in obese patients who participated in a lifestyle medicine program
Author(s) -
Eymard Torres-Rodriguez,
Lucy Cedillo-Ramírez
Publication year - 2021
Publication title -
revista de la facultad de medicina humana
Language(s) - English
Resource type - Journals
eISSN - 2308-0531
pISSN - 1814-5469
DOI - 10.25176/rfmh.v22i1.4095
Subject(s) - medicine , blood pressure , obesity , body mass index , physical therapy , diabetes mellitus , type 2 diabetes , lipid profile , observational study , metabolic syndrome , endocrinology
Lifestyle Medicine in the management of chronic diseases such as obesity is essential to reduce cardiovascular risk and to reverse the disease process (1). Objective: To determine if a Lifestyle Medicine program can reduce cardiovascular risk in obese adults in Colombia. Material and methods: Descriptive observational study cases series type followed for 6 months in a Lifestyle Medicine Clinic. 9 patients were included taking into account 2 measures of cardiovascular risk as a parameter to complete the program. The following measurements were taken: cardiovascular risk using the Pan American Health Organization (PAHO) calculator, Body Mass Index (BMI), lipid profile, history of smoking, history of diabetes, and systolic blood pressure. Results: Of the 9 obese patients, 22% had an intermediate cardiovascular risk and 78% had a low risk at the beginning of the study. After 6 months, it was achieved that 100% of the participants had a low cardiovascular risk; Furthermore, 11% of the patients managed to normalize their blood pressure values and 20% showed a decrease in high blood pressure values. In addition, 22% went from type 3 obesity to type 2 obesity. Finally, through psychological consultation, it was possible to reduce anxiety levels from high to intermediate in at least 44% of the participants. Conclusions: The Lifestyle Medicine program, in a group of obese patients, managed to achieve a low cardiovascular risk, the decrease and normalization of blood pressure figures and reduction in BMI in participants who completed the study.